ASLAN Investigative Site

Louisville, Kentucky 40217

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis — Completed
• Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab — Status unconfirmed